Product References
Photoreceptor laminin drives differentiation of human pluripotent stem cells to photoreceptor progenitors that partially restore retina function.
Molecular therapy : the journal of the American Society of Gene Therapy
Tay HG,Andre H,Chrysostomou V,Adusumalli S,Guo J,Ren X,Tan WS,Tor JE,Moreno-Moral A,Plastino F,Bartuma H,Cai Z,Tun SBB,Barathi VA,Siew Wei GT,Grenci G,Chong LY,Holmgren A,Kvanta A,Crowston JG,Petretto E,Tryggvason K
MA5-15873 was used in ELISA, Flow Cytometry, Immunocytochemistry, Immunohistochemistry, Western Blot to investigate the role of a human recombinant retina-specific laminin isoform, LN523 in promoting the differentiation of human embryonic stem cells into photoreceptor progenitors.
Wed Mar 01 00:00:00 UTC 2023
Lysine-specific demethylase 2A enhances binding of various nuclear factors to CpG-rich genomic DNAs by action of its CXXC-PHD domain.
Scientific reports
Iuchi S,Paulo JA
MA5-15873 was used in Western Blotting to propose that CXXC-PHD promotes permissiveness for nuclear factors to interact, but involvement of the XRCC5/6 complex in the recruitment is undetermined.
Tue Apr 02 00:00:00 UTC 2019
CAPRI enables comparison of evolutionarily conserved RNA interacting regions.
Nature communications
Panhale A,Richter FM,Ramírez F,Shvedunova M,Manke T,Mittler G,Akhtar A
MA5-15873 was used in Western Blotting to produce a method to map RNA-binding domains by simultaneous identification of RNA interacting crosslinked peptides and peptides adjacent to such crosslinked sites.
Tue Jun 18 00:00:00 UTC 2019
Tyrosine kinase inhibitor-induced defects in DNA repair sensitize FLT3(ITD)-positive leukemia cells to PARP1 inhibitors.
Blood
Maifrede S,Nieborowska-Skorska M,Sullivan-Reed K,Dasgupta Y,Podszywalow-Bartnicka P,Le BV,Solecka M,Lian Z,Belyaeva EA,Nersesyan A,Machnicki MM,Toma M,Chatain N,Rydzanicz M,Zhao H,Jelinek J,Piwocka K,Sliwinski T,Stoklosa T,Ploski R,Fischer T,Sykes SM,Koschmieder S,Bullinger L,Valent P,Wasik MA,Huang J,Skorski T
MA5-15873 was used in Western Blotting to suggest FLT3(ITD) could be used as a precision medicine marker for identifying AML patients that may benefit from a therapeutic regimen combining FLT3 and PARP1i's.
Thu Jul 05 00:00:00 UTC 2018
Gene expression and mutation-guided synthetic lethality eradicates proliferating and quiescent leukemia cells.
The Journal of clinical investigation
Nieborowska-Skorska M,Sullivan K,Dasgupta Y,Podszywalow-Bartnicka P,Hoser G,Maifrede S,Martinez E,Di Marcantonio D,Bolton-Gillespie E,Cramer-Morales K,Lee J,Li M,Slupianek A,Gritsyuk D,Cerny-Reiterer S,Seferynska I,Stoklosa T,Bullinger L,Zhao H,Gorbunova V,Piwocka K,Valent P,Civin CI,Muschen M,Dick JE,Wang JC,Bhatia S,Bhatia R,Eppert K,Minden MD,Sykes SM,Skorski T
MA5-15873 was used in Western Blot to conclude that GEMA-guided targeting of PARP1 resulted in dual cellular synthetic lethality in quiescent and proliferating immature leukemia cells, and is thus a potential approach to eradicate leukemia stem and progenitor cells that are responsible for initiation and manifestation of the disease.
Thu Jun 01 00:00:00 UTC 2017
IGH/MYC Translocation Associates with BRCA2 Deficiency and Synthetic Lethality to PARP1 Inhibitors.
Molecular cancer research : MCR
Maifrede S,Martin K,Podszywalow-Bartnicka P,Sullivan-Reed K,Langer SK,Nejati R,Dasgupta Y,Hulse M,Gritsyuk D,Nieborowska-Skorska M,Lupey-Green LN,Zhao H,Piwocka K,Wasik MA,Tempera I,Skorski T
MA5-15873 was used in Western Blotting to demonstrate that untreated and cytarabine (AraC)-treated IGH/MYC-positive BL cells accumulate a high number of potentially lethal DNA double-strand breaks (DSBs) and display low levels of the BRCA2 tumor suppressor protein, which is a key element of homologous recombination (HR)-mediated DSB repair.
Tue Aug 01 00:00:00 UTC 2017